TITLE

The human papillomavirus vaccine and risk of anaphylaxis

AUTHOR(S)
Halsey, Neal A.
PUB. DATE
September 2008
SOURCE
CMAJ: Canadian Medical Association Journal;9/9/2008, Vol. 179 Issue 6, p509
SOURCE TYPE
Academic Journal
DOC. TYPE
Editorial
ABSTRACT
The author reflects on a study which reveals higher than expected rates of apparent anaphylaxis following vaccination with the quadrivalent human papillomavirus (HPV) vaccine in children in Australia. He points out that the report failed to determine the causes of anaphylactoid reactions among children following the vaccination. In addition, he suggests the need to check the rate of anaphylaxis following HPV vaccination in other populations.
ACCESSION #
34077499

 

Related Articles

  • HPV vaccine mandate to begin in Washington, D.C. this fall. Zacharyczuk, Colleen // Infectious Diseases in Children;May2009, Vol. 22 Issue 5, p14 

    The article reports that sixth-grade girls in Washington, D.C. will be required to show that they have at least begun the series of immunizations for the human papillomavirus vaccine, beginning in the fall of 2009.

  • HPV vaccine linked to anaphylaxis risk.  // Contemporary OB/GYN;Oct2008, Vol. 53 Issue 10, p25 

    The article discusses research being done on the correlation between human papillomavirus (HPV) vaccine and the risk of anaphylaxis in Westmead, New South Wales. It references a study by Julia M. L. Brotherton et al., published in the September 1, 2008 issue of the "Canadian Medical Journal"...

  • Adolescent immunisation: the next big thing? Adam Finn // Archives of Disease in Childhood;Jun2011, Vol. 96 Issue 6, p497 

    The authors reflect on the initiation of the routine human papillomavirus (HPV) vaccine on the immunisation schedule for girls in Great Britain in 2008, which has strengthened the widespread immunisation of adolescents. The authors state that the immunisation programme has been successful with...

  • Safety of Human Papillomavirus Vaccines: A Review. Macartney, Kristine; Chiu, Clayton; Georgousakis, Melina; Brotherton, Julia // Drug Safety;2013, Vol. 36 Issue 6, p393 

    Vaccination to prevent human papillomavirus (HPV)-related infection leading to cancer, particularly cervical cancer, is a major public health breakthrough. There are currently two licensed HPV vaccines, both of which contain recombinant virus-like particles of HPV types 16 and 18 (which account...

  • Sensitivity reactions to HPV vaccines in schoolgirls are rare.  // Nursing Standard;1/28/2009, Vol. 23 Issue 21, p16 

    The article reports that researchers have found that hypersensitivity to the quadrivalent human papillomavirus (HPV) vaccine in school girls is uncommon. Skin testing, outcomes of clinical evaluation, and vaccine challenge were examined for 35 schoolgirls aged 12-18.9 years with suspected...

  • HPV VACCINE.  // Good Health & Medicine;Apr2009, p16 

    The article offers information on a study published in the "British Medical Journal" which shows that true hypersensitivity to the human papillomavirus (HPV) vaccine, also known as gardasil, is very rare. More than 380,000 girls in New South Wales and Victoria were given the HPV vaccine in 2007...

  • Human Papillomavirus (HPV) Vaccine (Cervarix).  // AHFS Consumer Medication Information;Jun2017, p1 

    What is HPV? HPV vaccine - Why get vaccinated? Who should get this HPV vaccine and when? Some people should not get HPV vaccine or should wait What are the risks from this vaccine? What if there is a severe reaction? The National Vaccine Injury Compensation Program How can I learn more?

  • Anaphylaxis reported following HPV vaccination.  // Hem/Onc Today;10/10/2008, Vol. 9 Issue 18, p13 

    This article reports that human papillomavirus (HPV) vaccine administration may yield more cases of anaphylaxis than other vaccines, according to a study published by Australia's National Center for Immunization Research and Surveillance of Vaccine Preventable Diseases. The study was conducted...

  • Untitled.  // American Family Physician;1/1/2008, Vol. 77 Issue 1, p117 

    The article presents the recommended immunization schedule for persons aged 0 to 18 in the U.S. Some of the suggested vaccines for infants to six-year-old children are hepatitis B vaccine, rotavirus vaccine, diphtheria and tetanus toxoids and acellular pertussis vaccine and varicella vaccine....

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics